Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03933462 · ClinicalTrials.gov registry record · NA
A Study for the Assessment of the Benefits of a Novel Mesh Nebulizer in the Treatment of Patients With Stable COPD
A NA study, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03933462 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 21 participants.
The verdict
NCT03933462, a NA study, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Jet nebulizers have been the standard delivery system for aerosolized medications commonly prescribed to Chronic Obstructive Pulmonary Disease (COPD) patients; however, these devices are inefficient and require an external pressurized gas source to operate. Vibrating mesh nebulizers have a significantly higher efficiency of delivering drugs to the lung compared to conventional jet or ultrasonic nebulizers because of the high fine particle fraction created by the rapid vibration. This post-market study will investigate the potential benefits of a vibrating mesh nebulizer compared a standard jet nebulizer. The study will include stable, ambulatory COPD patients who are currently using a jet nebulizer system. Participants will be asked to use each device for a period of 30 days. Patient preference and changes to quality of life will be evaluated.
Interventions
- DEVICE InnoSpire Go
- DEVICE Jet Nebulizer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2019-06-12 |
| Est. Completion | 2019-10-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03933462
The ClinicalTrials.gov registry entry for NCT03933462 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which InnoSpire Go is the first listed.
NCT03933462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03933462 about?
NCT03933462 is a clinical study titled "A Study for the Assessment of the Benefits of a Novel Mesh Nebulizer in the Treatment of Patients With Stable COPD". Jet nebulizers have been the standard delivery system for aerosolized medications commonly prescribed to Chronic Obstructive Pulmonary Disease (COPD) patients; however, these devices are inefficient and require an external pressurized gas source to operate. Vibrating mesh nebulizers have a significa...
What is the current status of trial NCT03933462?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2019-06-12. Estimated completion is 2019-10-28.
What interventions are being tested in trial NCT03933462?
The interventions under investigation include: InnoSpire Go (DEVICE), Jet Nebulizer (DEVICE).
Who is sponsoring clinical trial NCT03933462?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.